Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;95:e1-e7
Published online before print June 10, 2004, doi: 10.1161/01.RES.0000135547.53927.F6
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
95/1/e1    most recent
01.RES.0000135547.53927.F6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brette, F.
Right arrow Articles by Orchard, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brette, F.
Right arrow Articles by Orchard, C. H.
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Cell signalling/signal transduction
Right arrow Ion channels/membrane transport
(Circulation Research. 2004;95:e1.)
© 2004 American Heart Association, Inc.


UltraRapid Communication

Differential Modulation of L-type Ca2+ Current by SR Ca2+ Release at the T-Tubules and Surface Membrane of Rat Ventricular Myocytes

Fabien Brette*, Laurent Sallé*, Clive H. Orchard

From the School of Biomedical Sciences (F.B., C.H.O.), University of Leeds, Leeds, UK; and the Laboratoire de Physiologie Cellulaire (L.S.), Université de Caen, Caen, France.

Correspondence to Dr Fabien Brette, School of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, UK. E-mail f.brette{at}leeds.ac.uk


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
We have characterized modulation of ICa by Ca2+ at the t-tubules (ie, in control cells) and surface sarcolemma (ie, in detubulated cells) of cardiac ventricular myocytes, using the whole-cell patch clamp technique to record ICa. ICa inactivation was significantly slower in detubulated cells than in control cells (27.1±7.8 ms, n=22, versus 16.4±7.9 ms, n=22; P<0.05). In atrial myocytes, which lack t-tubules, ICa inactivation was not changed by the treatment used to produce detubulation. In the presence of ryanodine or BAPTA, or when Ba2+ was used as the charge carrier, the rate of inactivation was not significantly different in control and detubulated cells. Frequency-dependent facilitation occurred in control cells but not in detubulated cells, and was abolished by ryanodine. These results suggest that Ca2+ released from the SR has a greater effect on ICa in the t-tubules than at the surface sarcolemma. This does not appear to be due to differences in local Ca2+ release from the SR, because the gain of Ca2+ release was not significantly different in control and detubulated cells. These data suggest that the t-tubules are a key site for the regulation of transsarcolemmal Ca2+ flux by Ca2+ release from the SR; this could play a role in altered Ca2+ homeostasis in pathological conditions. The full text of this article is available online at http://circres.ahajournals.org.


Key Words: transverse tubules • calcium channel • inactivation • facilitation


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Calcium influx via the L-type Ca2+ current (ICa) is the major trigger for Ca2+ release from the sarcoplasmic reticulum (SR) of cardiac ventricular myocytes.1 This influx activates a cluster of adjacent SR Ca2+ release channels (ryanodine receptors; RyRs); the consequent systolic Ca2+ transient is the spatial and temporal sum of such local Ca2+ releases.2 The transverse (t-) tubules of ventricular myocytes play an important role in this process. These tubules are invaginations of the sarcolemma that occur at the Z-line, perpendicular to the longitudinal axis of the cell (see review).3 Functional and immunohistochemical data suggest that ICa occurs predominantly in the t-tubules, adjacent to RyRs, which are also located predominantly at the t-tubules.4–6 Thus, it appears that the t-tubules are the major site of Ca2+ entry and hence Ca2+ release in cardiac ventricular myocytes. Conversely, Ca2+ released by the SR can modulate ICa; this plays an important role in cellular Ca2+ homeostasis, controlling Ca2+ entry via negative feedback.7,8 However, it is unknown whether the efficacy of coupling between SR Ca2+ release and ICa is the same in the t-tubule and surface membranes, so that the relative importance of these sites in cellular Ca2+ homeostasis is unknown. We have, therefore, investigated the regulation of ICa by Ca2+ released from the SR in normal ventricular myocytes, in which ICa triggers Ca2+ release predominantly at the t-tubules, and in myocytes in which the t-tubules have been physically and functionally uncoupled from the surface membrane (detubulated),5 in which Ca2+ release occurs predominantly at the surface membrane.9


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
This study conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).

Isolation and Detubulation of Rat Ventricular Myocytes
Myocytes were isolated from the ventricles of Wistar rat hearts (Central Biomedical Services, University of Leeds, UK) and detubulated using formamide as described previously.5,9 All experiments were performed at room temperature (22 to 25°C).

Recording ICa
Most of the experiments described in this article used the whole-cell (ruptured) patch clamp technique10 using Na+ and K+-free internal and external solutions to avoid contamination of ICa by overlapping ionic currents and to allow us to use a physiological holding potential. An Axopatch 200B (Axon Instruments) voltage clamp amplifier was used, controlled by a Pentium PC connected via a Digidata 1322A A/D converter (Axon Instruments), which was also used for data acquisition and analysis using pClamp software (Axon Instruments). Signals were filtered at 2 kHz using an 8-pole Bessel low-pass filter before digitization at 10 kHz and storage. Low resistance (1 to 3 M{Omega}) patch pipettes were used and the junction potential between the pipette solution and the reference electrode was cancelled before obtaining a tight gigaseal (>1 G{Omega}). Cell membrane capacitance was measured by integrating the capacitance current recorded during a 10-mV hyperpolarizing pulse from –80 mV. Cell capacitance and series resistance were compensated (>70%) so that the maximum voltage error was <3.5 mV. ICa was recorded during a 200-ms test pulse to 0 mV from a holding potential of –80 mV. Trains of depolarizing pulses were applied at 0.1 or 1 Hz.

The experiments shown in Figure 4 were performed using the perforated patch clamp technique11 to record ICa and the Ca2+ transient simultaneously. Cells were loaded with the Ca2+ indicator Fura2-acetoxymethyl ester (AM, 3 µmol/L; Molecular Probes) for 10 minutes at room temperature. Fura2 fluorescence was elicited by alternate (every 2 ms) illumination with 340 and 380 nm light, obtained using a rotating filter wheel (Cairn Research Ltd) in front of a Xenon excitation lamp. The fluorescence emitted at 510 nm was monitored using a photomultiplier tube (Cairn Research Ltd). The ratio of fluorescence emitted at 510 nm during excitation at 340 nm to that emitted during excitation at 380 nm (R) is a function of [Ca2+]i, and was converted to [Ca2+]i as described in Data Analysis section. The tip of the patch electrode was filled with pipette solution and then back filled with the same solution containing 250 to 400 µg/mL amphotericin-B (Sigma). After seal formation and pipette capacitance compensation, holding potential was set to –40 mV, and 5 mV, 20-ms depolarizing pulses were applied to monitor pore formation. The pipette solution contained 1 mmol/L CaCl2 to ensure cell death on accidental rupture of the membrane. Electrical access was typically obtained within 10 minutes and measurements were made after the capacitance transients became constant. ICa was recorded during a 500-ms test pulse to 0 mV from a holding potential of –40 mV. Trains of depolarizing pulses were applied at 0.2 Hz.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 4. Relationship between ICa and {Delta}[Ca2+]i in control and detubulated rat ventricular myocytes. A, Ca2+ transient (top trace in each panel) and ICa (bottom trace) in representative control (left) and detubulated (right) myocytes, elicited at 0 mV. B, Mean (±SEM) for control (black bars; n=14) and detubulated (white bars; n=16) myocytes: a, ICa density (left) and T0.37 (right); b, {Delta}[Ca2+]i (left) and d[Ca2+]i/dtmax (right); c, time to d[Ca2+]i/dtmax (left) and (d[Ca2+]i/dtmax)/{Delta}[Ca2+]i (right); and d, Gain measured as {Delta}[Ca2+]i/ICa (left) and (d[Ca2+]i/dtmax)/ICa (right). See text for further details. *P<0.05 between cell types.

Solutions
Myocytes were studied in a chamber mounted on the stage of an inverted microscope (Nikon Diaphot). Cells were initially superfused with a normal physiological salt solution containing (in mmol/L) NaCl 113, KCl 5, MgSO4 1, CaCl2 1, Na2HPO4 1, Na acetate 20, glucose 10, HEPES 10, and insulin 5 U/L; pH set to 7.4 with NaOH.

When ICa was measured using the ruptured whole-cell patch clamp configuration, the pipette solution contained (in mmol/L) CsCl 110, TEACl 20, MgCl2 0.5, Mg-ATP 5, EGTA 5, HEPES 10, and GTPTris 0.4; set to pH 7.2 with CsOH. A fast perfusion system placed close to the cell was used to deliver the external solution, which contained (in mmol/L) 4AP 5, TEACl 130, MgCl2 0.5, HEPES 10, Glucose 10, and CaCl2 1. At least 5 minutes was allowed for cell dialysis by the pipette solution before experiments were initiated.

When ICa was measured using the perforated whole-cell patch clamp configuration, the pipette solution contained (in mmol/L) CsCl 130, NaCl 10, MgCl2.6H2O 1, HEPES 10, and CaCl2 1; pH set to 7.2 using CsOH. CsCl (5 mmol/L) was also added to the normal physiological (extracellular) solution to prevent IK contamination.

Data Analysis
ICa was measured as the difference between the peak inward current and the current at the end of the depolarizing pulse. Currents are expressed as current density (pA/pF). Because the decay of ICa varied between cell types and experimental conditions, the kinetics of inactivation of ICa were characterized by the time required for the current to decay to 0.37 of the peak amplitude (T0.37). Most currents decayed monoexponentially, in which case T0.37 is equivalent to the time constant of decay. However in control cells, the decay was biexponential, in which case T0.37 is used as a simple measure to compare the time course of decay in these cells with that in detubulated and treated cells. Frequency-dependent facilitation was analyzed by integrating ICa (pA·ms) during the 200 ms test pulse to obtain total Ca2+ influx during the pulse.

[Ca2+]i was calculated from [Ca2+]i=Kdß(R–Rmin)/(Rmax–R).12 Rmax, Rmin, and ß were determined experimentally and Kd taken as 200 nmol/L.13 Traces were averaged (10 to 15 transients); the difference between diastolic and peak [Ca2+]i was taken as {Delta}[Ca2+]i, and the maximum rate of change of [Ca2+]i (d[Ca2+]i/dtmax) was calculated using Origin software. {Delta}[Ca2+]i/ICa and (d[Ca2+]i/dtmax)/ICa were taken as commonly used and useful approximations1 of the gain of the Ca2+ release process as defined by Wier et al.14

Statistics
Data are presented as mean±SD in the text and mean±SEM in the figures. Statistical analysis was performed using SigmaStat software. A two-tailed unpaired t test was used to compare data from control and formamide treated cells when normal distribution and equal variance were confirmed, otherwise a nonparametric test (Mann-Whitney rank sum) was used. Paired t tests were used to test the effect of ryanodine or Ba2+ within the same group of cells. A value of P<0.05 was taken as significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Detubulation Slows ICa Inactivation
Figure 1A shows recordings of ICa elicited by test pulses from –80 to 0 mV in representative control and detubulated ventricular myocytes. Detubulation decreased ICa density, confirming that this current is concentrated in the t-tubules.5 These traces also show that ICa recorded from control myocytes showed biphasic inactivation whereas ICa recorded from detubulated myocytes showed monophasic inactivation. Detubulation of ventricular myocytes significantly decreased cell capacitance and ICa density (193±22 pF and –12.6±5.7 pA/pF respectively in control, n=22; 137±34 pF and –5.3±2.2 pA/pF in detubulated cells, n=22; P<0.05; Figure 1B). The time required for the current to decay to 0.37 of its peak amplitude (T0.37) was significantly longer in detubulated cells (27.1±7.8 ms, n=22) than in control cells (16.4±7.9 ms, n=22, P<0.05; Figure 1B).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 1. ICa in control and detubulated rat ventricular myocytes. A, ICa elicited at 0 mV in representative control (left) and detubulated (right) myocytes. B, Mean±SEM cell capacitance (left), ICa density at 0 mV (middle), and time for ICa to decay to 0.37 of peak amplitude (T0.37; right) in control (n=22, black bars) and detubulated (n=22, open bars) myocytes. *P<0.05 between cell types.

To ensure that the slowed inactivation of ICa was not due to a direct effect of formamide, the effect of formamide treatment on ICa was determined in atrial cells, which lack t-tubules.9 ICa was recorded in atrial myocytes using the same solutions and experimental conditions as for ventricular myocytes except that the holding potential was set to –40 mV in order to inactivate T-type Ca2+ current. In contrast to ventricular myocytes, ICa elicited at 0 mV showed biphasic inactivation in control and formamide-treated atrial myocytes (Figure 2A), and formamide treatment of atrial cells had no significant effect on cell capacitance, ICa density or T0.37 (Figure 2B).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 2. ICa in control and formamide-treated rat atrial myocytes. A, ICa elicited at 0 mV in representative control (left) and formamide-treated (right) atrial myocytes. B, Mean (±SEM) cell capacitance (left), ICa density at 0 mV (middle), and time for ICa to decay to 0.37 of peak amplitude (T0.37; right) in control (n=7, black bars) and formamide-treated (n=7, open bars) atrial myocytes. There were no significant differences between control and formamide-treated atrial myocytes.

Thus it appears that in ventricular myocytes the rate of inactivation of ICa is different at the t-tubules and the surface membrane. Subsequent experiments were designed to investigate the mechanism(s) underlying this difference.

ICa Inactivation Due to Ca2+ Released From the SR
The inactivation phase of ICa is due to two mechanisms: voltage-dependent inactivation (VDI) and Ca2+-dependent inactivation (CDI).7 To investigate whether VDI is altered by detubulation we recorded ICa using Ba2+ as the charge carrier, to eliminate CDI.7 IBa was recorded at –10 mV to compensate for screening of surface charge.15 The top panel of Figure 3A shows representative currents from control and detubulated ventricular myocytes recorded using Ca2+ (gray trace) or Ba2+ (black trace) as the charge carrier; the currents have been normalized to allow comparison of their time course. Inactivation of IBa was not significantly different in control and detubulated myocytes (T0.37: 72±7 ms, n=7 control, versus 79±15, n=8 detubulated; P>0.05; Figure 3B), suggesting that VDI is the same at the t-tubules and the surface membrane. These results, and the observation that the rapid phase of inactivation, which is due to CDI,7 is reduced in detubulated myocytes (eg, Figure 3A, top panel), suggest that CDI rather than VDI is reduced in detubulated myocytes.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 3. Effects of Ba2+, ryanodine, and BAPTA on inactivation of ICa in control and detubulated rat ventricular myocytes. A, ICa in representative control (left) and detubulated (right) myocytes. Top, ICa with 1 mmol/L Ca2+ (gray traces) or 1 mmol/L Ba2+ (black traces) as the charge carrier in the same cell. Middle, ICa in the absence (gray traces) or presence (black traces) of 30 µmol/L ryanodine in the same cell. Bottom, ICa when 5 mmol/L EGTA has been replaced with 10 mmol/L BAPTA in the pipette solution. Currents are normalized and elicited at 0 mV except when using Ba2+ as a charge carrier (–10 mV; see text). B, Mean (±SEM) time for ICa to decay to 0.37 of peak amplitude in control (black bar) and detubulated (open bar) myocytes when Ba2+ was used as the charge carrier (n=7 and 8, respectively; left), in the presence of ryanodine (30 µmol/L; n=13 and 13; middle), and with BAPTA in the pipette solution (n=8 and 9; right). There were no significant differences between control and detubulated myocytes.

In ventricular myocytes, CDI is due in part to Ca2+ released from the SR.16,17 The SR inhibitor ryanodine (30 µmol/L) was therefore used to investigate the role of SR Ca2+ release in the decrease of CDI observed in detubulated myocytes. Ryanodine significantly slowed inactivation and prolonged ICa in control and detubulated myocytes (Figure 3A, middle panels); however, this effect was greater in control cells, so that in the presence of ryanodine, T0.37 was not significantly different in control and detubulated myocytes (29.7±4.8 ms, n=13, versus 32.9±8.3, n=13, respectively; P>0.05; Figure 3B; cf, Figure 1B, right). This suggests, in agreement with previous work,16–20 that Ca2+ release from the SR inactivates ICa; however, this effect is reduced after detubulation, suggesting that SR Ca2+ release has a greater effect on ICa inactivation in the t-tubules than at the surface membrane. Including the fast Ca2+ chelator BAPTA (10 mmol/L) in the pipette solution had similar effects (Figure 3A, bottom, and 3B).

The decreased effect of SR Ca2+ release on ICa inactivation in detubulated cells could be explained if ICa triggered less SR Ca2+ release at the surface membrane. To address this hypothesis, we simultaneously recorded ICa and intracellular Ca2+.

Effect of Detubulation on ICa-Induced Ca2+ Release
The left traces in Figure 4A show representative recordings of [Ca2+]i (top) and ICa (bottom) from a control myocyte during a pulse to 0 mV. Under these conditions, the majority of L-type Ca2+ current and Ca2+ release occur at the t-tubule (see Introduction). The right traces in Figure 4A show corresponding recordings from a detubulated cell. In these cells, the amplitude of ICa and the Ca2+ transient are reduced, as reported previously,5 and are determined predominantly by Ca2+ entry and release at the surface membrane.9 The decay of the Ca2+ transient is also slower because Na+-Ca2+ exchange occurs predominantly in the t-tubules.21,22

Figure 4B shows mean data from 14 control and 16 detubulated cells. Figure 4B, a, shows that ICa density was significantly reduced (left) and T0.37 for ICa inactivation significantly prolonged (right) in detubulated cells, as in the previous set of experiments (cf, Figure 1). {Delta}[Ca2+]i and d[Ca2+]i/dtmax were significantly smaller after detubulation (Figure 4B, b), although the time to d[Ca2+]i/dtmax, and d[Ca2+]i/dtmax normalized to {Delta}[Ca2+]i ((d[Ca2+]i/dtmax)/{Delta}[Ca2+]i) were the same in the two cell types (Figure 4B, c) The gain of the Ca2+ release process was calculated in two ways (see Materials and Methods); Figure 4B, d, shows that there was a modest ({approx} 20%) but nonsignificant decrease in gain, determined using either method in detubulated myocytes. Thus, the effectiveness of ICa in causing SR Ca2+ release is not significantly different in the two cell types and, therefore, at the t-tubules and surface membrane. Thus, it appears that the slowing of ICa inactivation after detubulation cannot be explained by a decrease in local SR Ca2+ release; it is more likely that a given SR Ca2+ release has less effect on ICa inactivation at the surface membrane than in the t-tubules.

Effect of Detubulation on ICa Facilitation
To investigate this idea further, we studied the response of control and detubulated myocytes to an increase in stimulation rate, which causes frequency-dependent facilitation (FDF) of ICa that is dependent, in part, on SR Ca2+ release.18 FDF in a representative control cell is shown in Figure 5A (top, left) as increased amplitude and slowed inactivation of ICa during the fourth voltage clamp pulse from –80 to 0 mV after an increase in stimulation rate from 0.1 to 1 Hz. The SR inhibitor ryanodine (30 µmol/L) slowed the time course of inactivation, and abolished FDF (Figure 5A, bottom left). The right traces in Figure 5A show that FDF was absent in detubulated cells in either the absence (top) or presence (bottom) of ryanodine. Figure 5B shows that ICa, expressed as the integral of the current, increased significantly in control cells when stimulation rate was increased but not in detubulated cells (I4/I1=1.34±0.23, n=11, and 0.97±0.08, n=13, respectively), nor was there any significant change in either control or detubulated cells in the presence of ryanodine (I4/I1=0.96±0.06 and 0.98±0.09, respectively). Inclusion of BAPTA in the patch pipette, or use of Ba2+ as the charge carrier, also abolished FDF (not shown). These data support the idea that the effect of SR Ca2+ release on ICa is smaller at the surface membrane than in the t-tubules.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 5. Frequency-dependent facilitation of ICa in control and detubulated myocytes. A, ICa recorded in response to the first (1) and the fourth (4) pulse to 0 mV after increasing stimulation rate from a steady state at 0.1 Hz to 1 Hz (schematic protocol shown above the traces) in representative control (left) and detubulated (right) myocytes in the absence (top) and presence (bottom) of ryanodine in the same cell. B, Mean (±SEM) changes in ICa charge (integral) between the 1st and 4th ICa after increasing stimulation rate in control (n=11, black bars) and detubulated (n=13, open bars) myocytes in the absence (left) and presence (right) of ryanodine. *P<0.05 between cell types;, #P<0.05 between treatments.

Quantification of CDI
The principal findings of this study are summarized in the Table. To quantify inactivation of ICa, we measured the fraction of current remaining 20 ms after its peak (IR20). This time was chosen because the peak of SR Ca2+ release occurs {approx}5 ms after peak ICa, with a time to 90% decay of {approx}45 ms.23


View this table:
[in this window]
[in a new window]
 
Table 1. Fraction of ICa Remaining 20 ms After its Peak, and Proportion of CDI in Control and Detubulated Myocytes

When Ba2+ is used as the charge carrier, ICa inactivates almost exclusively by VDI, and IR20Ba was not significantly different between control and detubulated myocytes (Table). When Ca2+ is used as the charge carrier, ICa inactivates by VDI and CDI. Thus the difference between ICa and IBa represents the current inactivated by CDI. By normalizing to IR20Ba{ie, [(I R20BaIR20Ca)/I R20Ba]x100]}, we estimate total CDI to be {approx}62% in control and {approx}40% in detubulated myocytes (Table).

To separate SR-induced CDI from total CDI, we used a similar analysis, comparing IR20Ca in the presence and absence of ryanodine. The difference current between ICa and ICa in the presence of ryanodine represents the fraction of ICa inactivated by SR CDI. By normalizing to total CDI {ie, [(IR20RyaIR20Ca)/(IR20Ba–IR20Ca)]x100}, we estimate the SR CDI to be {approx}40% of total CDI in control myocytes and {approx}8% in detubulated myocytes (table 1). Correcting for the 10% of cells that remain non-detubulated following formamide treatment, we can calculate that {approx}20% of ICa is located at the surface membrane (see Discussion) and thus that SR-dependent CDI at the t-tubules is {approx}50%, and {approx}5% at the surface membrane.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
Experimental Approach
The method used to detubulate rat ventricular myocytes has been described and validated previously.9 The observed effects are unlikely to be due to formamide treatment per se because no changes were observed in atrial cells (Figure 2 and Brette et al).9

The decrease in ICa and cell capacitance after formamide treatment, and correction for the presence of 10% nondetubulated myocytes (assessed as in Despa et al21), indicate that {approx}80% of ICa is within the t-tubules, so that the density of ICa in the t-tubules is {approx}6 fold higher than in the surface membrane. Thus, Ca2+ signaling in control cells is dominated by the t-tubules, whereas Ca2+ signaling in detubulated cells occurs predominantly at the cell surface.

It is well known that there is bidirectional cross-talk between ICa and RyRs in cardiac myocytes.1 This local Ca2+ signaling occurs in a restricted diffusion space; the use of a low concentration of slow Ca2+ buffer (EGTA)24 as in the present study allows Ca2+ in the bulk cytosol to be "clamped" (indicated by the absence of cell contraction) while permitting Ca2+ in the dyadic space to change (indicated by the effect of ryanodine on ICa), whereas a faster Ca2+ chelator (BAPTA) inhibits this local signaling, slowing the rate of inactivation of ICa to the same level in control and detubulated myocytes (Figure 3). This local Ca2+ signaling has been observed in numerous studies recording ICa using EGTA to buffer bulk Ca2+,16,18–20,23 and Song et al23 have demonstrated such signaling directly using confocal microscopy to show ICa-induced Ca2+ release in the dyadic space ("Ca2+ spikes") in the presence of EGTA. The solutions used in the present study allowed ICa to be recorded without contamination by Na+-Ca2+ exchange current, which is concentrated in the t-tubules.21,22 Such contamination could alter the shape of ICa, particularly from the physiological holding potential used (–80 mV), which is necessary to elicit FDF.7

Modulation of ICa by SR Ca2+ Release Is Smaller at Surface Sarcolemma Than T-Tubule
Ca2+ entering the cell through the L-type Ca2+ channel, and Ca2+ released from the SR, appear to bind to calmodulin (CaM) that is prebound to the Ca2+ channel, causing channel inactivation.25 Figure 3A shows such Ca2+-dependent inactivation; inhibition of SR Ca2+ release by ryanodine slowed the time course of inactivation in control cells. In detubulated cells, the time course of inactivation of ICa was slower than in control cells; this is probably due to lack of feedback of Ca2+ released from the SR rather than to smaller Ca2+ influx, because T0.37 was little affected by ryanodine in detubulated cells, and was the same in control and detubulated cells in the presence of ryanodine (Figure 1B) despite differences in the amplitude of ICa. It is also unlikely that this prolongation of T0.37 occurs because of the solutions used for cell dialysis, because T0.37 was also longer in detubulated myocytes in perforated patch experiments (Figure 4B, a), suggesting that this phenomenon exists in physiological conditions. Although absolute T0.37 was slower in both cell types compared with ruptured patch experiments, probably due to the difference in holding potential, the ratio of T0.37 in detubulated:control myocytes in perforated patch (1.53) was similar to that in the ruptured patch experiments (1.65).

The idea that Ca2+ released from the SR has less effect on inactivation of ICa in detubulated cells is supported by the observations that FDF did not occur in control cells in the presence of ryanodine (showing that it is due to SR Ca2+ release), that it did not occur in detubulated cells and that ryanodine had no effect on the response of ICa to increasing stimulation rate in detubulated cells. FDF may be a consequence of Ca2+ binding to CaM on the Ca2+ channel,25 phosphorylation of the channel after activation of Ca2+/calmodulin–dependent protein kinase II (CaMKII)26,27 or to less Ca2+-dependent inactivation of ICa.18

ICa-Induced SR Ca2+ Release Is the Same at the T-Tubules and Surface Membrane
Although SR Ca2+ release had a greater effect on ICa at the t-tubules than at the surface membrane, the gain of the Ca2+ release process was not significantly altered by detubulation. Our experimental conditions precluded analysis of gain as first defined by Wier et al;14 instead, we used two methods widely accepted as useful approximations:1 {Delta}[Ca2+]i/ICa and (d[Ca2+]i/dtmax)/ICa. {Delta}[Ca2+]i, and hence {Delta}[Ca2+]i/ICa might be overestimated in detubulated myocytes because of the spatially and temporally inhomogeneous Ca2+ transient,22,28 so we also used d[Ca2+]i/dtmax. However, neither method showed a significant change in gain, nor was the time to d[Ca2+]i/dtmax altered after detubulation. This suggests that coupling of Ca2+ release to Ca2+ influx is the same in control and detubulated cells, and hence at the t-tubules and surface membrane; differences in such coupling would be expected to alter these measures.29 These data agree with previous work showing that the rate of rise of Ca2+ is the same at the cell periphery after detubulation as at the periphery and center of control myocytes, using confocal microscopy.9,28

Thus, it is unlikely that the smaller effect of SR Ca2+ release on ICa at the surface membrane is due to less local Ca2+ release, because feed-forward (ICa to SR Ca2+ release) is the same but feedback (SR Ca2+ release to ICa) is smaller at the surface membrane than in the t-tubules. A possible explanation for this dyadic rectification is considered next.

Possible Mechanisms for Differential Modulation of ICa by SR Ca2+ Release
There are a number of possible explanations for why ICa is affected more by SR Ca2+ release at the t-tubules than at the surface membrane: (1) Ca2+-dependent modulation of ICa depends on local Ca2+ entry and local Ca2+ release16; the present data could be explained if either is different in detubulated cells. It is unlikely that differences in local Ca2+ entry can account for the present observations, because in the presence of ryanodine, the rate of inactivation of ICa was the same in control and detubulated cells (Figure 3). It is also unlikely that differences in local Ca2+ release are responsible, because this appears to be the same at the t-tubules and surface membrane (above), consistent with previous work showing that SR Ca2+ content (assessed using caffeine) is not altered by detubulation.22,28 (2) Ca2+ entering the cytoplasm via ICa and from the SR enters a restricted diffusion space in which high [Ca2+] occurs before Ca2+ diffuses to the bulk cytosol.1 The present data could be explained if the rise of Ca2+ in this space, and sensed by the Ca2+ channel, were lower at the surface sarcolemma. This could occur if the dyadic space is less restricted at the surface membrane than at the t-tubules, allowing Ca2+ released from the SR to diffuse away rapidly, or if RyR and ICa are less well colocalized at the surface membrane; either could result in a rise of Ca2+ around the Ca2+ channel that is too small or brief to affect ICa. However, this seems unlikely because electron microscopy has shown no difference in the size of the dyadic space at the surface sarcolemma and t-tubules,30 and immunocytochemistry has shown similar colocalization of ICa and RyR4,6 at the two sites. In addition, any differences in the geometry and/or structure of the dyadic cleft would be expected to alter the gain of Ca2+ release and the rate of rise of Ca2+,29 both of which appear to be unaltered after detubulation. (3) The sensitivity of ICa to Ca2+ could be different at the 2 sites. This could be due to different channel isoforms; although several different isoforms have been found in ventricular myocytes,31 we are unaware of any evidence that they are differentially located between the t-tubule and surface membranes. Alternatively, CaM or CaMKII may regulate ICa more effectively at the t-tubules as a consequence of concentration of these proteins at the t-tubules26 or closer colocalization with the channel. This could explain why ICa-induced SR Ca2+ release is the same at both sites, whereas the feedback is different. We have recently shown such localized regulation of ICa by protein kinase A at the t-tubules.28

Physiological Significance
Previous work has shown that Na+-Ca2+ exchange is concentrated in the t-tubules and is more sensitive to Ca2+ released from the SR than to bulk cytoplasmic Ca2+.8,22,32 The present work shows that ICa is concentrated in the t-tubules and is regulated more effectively by SR Ca2+ release at the t-tubules than at the surface membrane. These data suggest that Ca2+ released from the SR will stimulate Ca2+ efflux via Na+-Ca2+ exchange, and inhibit Ca2+ influx via ICa, most effectively at the t-tubules. Thus, the t-tubules appear to be the primary site at which changes in SR Ca2+ release bring about compensatory changes in transsarcolemmal Ca2+ flux8 and are therefore central to cellular Ca2+ homeostasis.22 This may also be important during development and in pathological conditions (see review);3 for example, during heart failure, t-tubule density decreases3 and FDF is blunted33,34; this could be explained by the present work.


*    Acknowledgments
 
This study was supported by the Wellcome Trust and British Heart Foundation, including a travel grant to L.S. from the Wellcome Trust.


*    Footnotes
 
*Both authors contributed equally to this study. Back

Original received July 1, 2003; resubmission received February 25, 2004; revised resubmission received May 28, 2004; accepted June 3, 2004.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Bers DM. Excitation-contraction coupling and cardiac contractile force, 2nd ed. Dordrecht, Netherlands: Kluwer Academic; 2001.

2. Wier WG, Balke CW. Ca2+ release mechanisms, Ca2+ sparks, and local control of excitation-contraction coupling in normal heart muscle. Circ Res. 1999; 85: 770–776.[Free Full Text]

3. Brette F, Orchard CH. T-tubule function in mammalian cardiac myocytes. Circ Res. 2003; 92: 1182–1192.[Abstract/Free Full Text]

4. Carl SL, Felix K, Caswell AH, Brandt NR, Ball WJ Jr, Vaghy PL, Meissner G, Ferguson DG. Immunolocalization of sarcolemmal dihydropyridine receptor and sarcoplasmic reticular triadin and ryanodine receptor in rabbit ventricle and atrium. J Cell Biol. 1995; 129: 672–682.[Medline] [Order article via Infotrieve]

5. Kawai M, Hussain M, Orchard CH. Excitation-contraction coupling in rat ventricular myocytes after formamide-induced detubulation. Am J Physiol. 1999; 277: H603–H609.[Medline] [Order article via Infotrieve]

6. Scriven DR, Dan P, Moore ED. Distribution of proteins implicated in excitation-contraction coupling in rat ventricular myocytes. Biophys J. 2000; 79: 2682–2691.[Medline] [Order article via Infotrieve]

7. Bers DM, Perez-Reyes E. Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release. Cardiovasc Res. 1999; 42: 339–360.[Abstract/Free Full Text]

8. Eisner DA, Choi HS, Diaz ME, O’Neill SC, Trafford AW. Integrative analysis of calcium cycling in cardiac muscle. Circ Res. 2000; 87: 1087–1094.[Abstract/Free Full Text]

9. Brette F, Komukai K, Orchard CH. Validation of formamide as a detubulation agent in isolated rat cardiac cells. Am J Physiol. 2002; 283: H1720–H1728.

10. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981; 391: 85–100.[CrossRef][Medline] [Order article via Infotrieve]

11. Horn R, Marty A. Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol. 1988; 92: 145–159.[Abstract/Free Full Text]

12. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985; 260: 3440–3450.[Abstract/Free Full Text]

13. Sipido KR, Wier WG. Flux of Ca2+ across the sarcoplasmic reticulum of guinea-pig cardiac cells during excitation-contraction coupling. J Physiol (Lond). 1991; 435: 605–630.[Abstract/Free Full Text]

14. Wier WG, Egan TM, Lopez-Lopez JR, Balke CW. Local control of excitation-contraction coupling in rat heart cells. J Physiol (Lond). 1994; 474: 463–471.[Abstract/Free Full Text]

15. Hille B. Ionic channels of excitable membranes, 2nd ed. Sunderland, Mass: Sinauer Associates Inc; 1992.

16. Adachi-Akahane S, Cleemann L, Morad M. Cross-signaling between L-type Ca2+ channels and ryanodine receptors in rat ventricular myocytes. J Gen Physiol. 1996; 108: 435–454.[Abstract/Free Full Text]

17. Sipido KR, Callewaert G, Carmeliet E. Inhibition and rapid recovery of Ca2+ current during Ca2+ release from sarcoplasmic reticulum in guinea pig ventricular myocytes. Circ Res. 1995; 76: 102–109.[Abstract/Free Full Text]

18. Delgado C, Artiles A, Gomez AM, Vassort G. Frequency-dependent increase in cardiac Ca2+ current is due to reduced Ca2+ release by the sarcoplasmic reticulum. J Mol Cell Cardiol. 1999; 31: 1783–1793.[CrossRef][Medline] [Order article via Infotrieve]

19. Sham JS, Cleemann L, Morad M. Functional coupling of Ca2+ channels and ryanodine receptors in cardiac myocytes. Proc Natl Acad Sci U S A. 1995; 92: 121–125.[Abstract/Free Full Text]

20. Sham JS. Ca2+ release-induced inactivation of Ca2+ current in rat ventricular myocytes: evidence for local Ca2+ signalling. J Physiol. 1997; 500: 285–295.[Abstract/Free Full Text]

21. Despa S, Brette F, Orchard CH, Bers DM. Na/Ca exchange and Na/K-ATPase function are equally concentrated in transverse tubules of rat ventricular myocytes. Biophys J. 2003; 85: 3388–3396.[Medline] [Order article via Infotrieve]

22. Yang Z, Pascarel C, Steele DS, Komukai K, Brette F, Orchard CH. Na+-Ca2+ exchange activity is localized in the t-tubules of rat ventricular myocytes. Circ Res. 2002; 91: 315–322.[Abstract/Free Full Text]

23. Song LS, Sham JS, Stern MD, Lakatta EG, Cheng H. Direct measurement of SR release flux by tracking ‘Ca2+ spikes’ in rat cardiac myocytes. J Physiol. 1998; 512: 677–691.[Abstract/Free Full Text]

24. Tsien RY. New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry. 1980; 19: 2396–2404.[CrossRef][Medline] [Order article via Infotrieve]

25. Zuhlke RD, Pitt GS, Deisseroth K, Tsien RW, Reuter H. Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature. 1999; 399: 159–162.[CrossRef][Medline] [Order article via Infotrieve]

26. Wu Y, MacMillan LB, McNeill RB, Colbran RJ, Anderson ME. CaM kinase augments cardiac L-type Ca2+ current: a cellular mechanism for long Q-T arrhythmias. Am J Physiol. 1999; 276: H2168–H2178.[Medline] [Order article via Infotrieve]

27. Yuan W, Bers DM. Ca-dependent facilitation of cardiac Ca current is due to Ca-calmodulin- dependent protein kinase. Am J Physiol. 1994; 267: H982–H993.[Medline] [Order article via Infotrieve]

28. Brette F, Rodriguez P, Komukai K, Colyer J, Orchard CH. ß-Adrenergic stimulation restores the Ca transient of ventricular myocytes lacking t-tubules. J Mol Cell Cardiol. 2004; 36: 265–275.[CrossRef][Medline] [Order article via Infotrieve]

29. Soeller C, Cannell MB. Numerical simulation of local calcium movements during L-type calcium channel gating in the cardiac diad. Biophys J. 1997; 73: 97–111.[Medline] [Order article via Infotrieve]

30. Page E. Quantitative ultrastructural analysis in cardiac membrane physiology. Am J Physiol. 1978; 235: C147–C158.[Medline] [Order article via Infotrieve]

31. Yang Y, Chen X, Margulies K, Jeevanandam V, Pollack P, Bailey BA, Houser SR. L-type Ca2+ channel alpha 1c subunit isoform switching in failing human ventricular myocardium. J Mol Cell Cardiol. 2000; 32: 973–984.[CrossRef][Medline] [Order article via Infotrieve]

32. Weber CR, Piacentino V, III, Ginsburg KS, Houser SR, Bers DM. Na+-Ca2+ exchange current and submembrane [Ca2+] during the cardiac action potential. Circ Res. 2002; 90: 182–189.[Abstract/Free Full Text]

33. Piot C, Lemaire S, Albat B, Seguin J, Nargeot J, Richard S. High frequency–induced upregulation of human cardiac calcium currents. Circulation. 1996; 93: 120–128.[Abstract/Free Full Text]

34. Sipido KR, Stankovicova T, Flameng W, Vanhaecke J, Verdonck F. Frequency dependence of Ca2+ release from the sarcoplasmic reticulum in human ventricular myocytes from end-stage heart failure. Cardiovasc Res. 1998; 37: 478–488.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Exp PhysiolHome page
C. H. Orchard, M. Pasek, and F. Brette
The role of mammalian cardiac t-tubules in excitation-contraction coupling: experimental and computational approaches
Exp Physiol, May 1, 2009; 94(5): 509 - 519.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Orchard and F. Brette
t-tubules and sarcoplasmic reticulum function in cardiac ventricular myocytes
Cardiovasc Res, January 15, 2008; 77(2): 237 - 244.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Altamirano and D. M. Bers
Voltage Dependence of Cardiac Excitation Contraction Coupling: Unitary Ca2+ Current Amplitude and Open Channel Probability
Circ. Res., September 14, 2007; 101(6): 590 - 597.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. M. Faber and Y. Rudy
Calsequestrin mutation and catecholaminergic polymorphic ventricular tachycardia: A simulation study of cellular mechanism
Cardiovasc Res, July 1, 2007; 75(1): 79 - 88.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
F. Brette and C. Orchard
Resurgence of Cardiac T-Tubule Research
Physiology, June 1, 2007; 22(3): 167 - 173.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Brette and C. H. Orchard
No Apparent Requirement for Neuronal Sodium Channels in Excitation-Contraction Coupling in Rat Ventricular Myocytes
Circ. Res., March 17, 2006; 98(5): 667 - 674.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L.-S. Song, E. A. Sobie, S. McCulle, W. J. Lederer, C. W. Balke, and H. Cheng
Orphaned ryanodine receptors in the failing heart.
PNAS, March 14, 2006; 103(11): 4305 - 4310.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
95/1/e1    most recent
01.RES.0000135547.53927.F6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brette, F.
Right arrow Articles by Orchard, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brette, F.
Right arrow Articles by Orchard, C. H.
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Cell signalling/signal transduction
Right arrow Ion channels/membrane transport